Rosetta Files to Float 3.45M Shares on Nasdaq; Israeli microRNA Firm Could Net $37.1M in IPO

/Home/Biologics Delivery - Protein Synthesis/RNA - Protein Synthesis/RNAi - Protein Synthesis

Rosetta Files to Float 3.45M Shares on Nasdaq; Israeli microRNA Firm Could Net $37.1M in IPO
By Doug Macron
September 7, 2006
RNAi News
Should the IPO go forward, Rosetta Genomics would become the first publicly traded pure-play microRNA company.
Paid subscription is required to view article.